Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic and Phenotypic Diversity of Carbapenemase-producing Escherichia Coli Strains Circulating in Southern France. The "CARBA-COLI" Study

NCT07676513 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT07676513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07676513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic and Phenotypic Diversity of Carbapenemase-producing Escherichia Coli Strains Circulating in Southern France. The "CARBA-COLI" Study
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 1, 2028
Enrollment
163 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistance, carbapenem-resistant enterobacteriaceae infection, colonization, enterobacteriaceae infections